Distek’s New ezfill+ Dissolution Media Preparation System Now Offers Data Integrity Support

November 3, 2020
Distek, Inc.

Distek, Inc., recently released its new ezfill+. Similar to its predecessor, the ezfill 4500, the ezfill+ allows rapid, effective deaeration and precise media volume delivery.

Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry has just released its new ezfill+. Like the ezfill 4500 predecessor, the ezfill+ allows rapid, effective deaeration and precise media volume delivery. In addition, the new ezfill+ includes a touch screen and intuitive user interface that allow stored methods, users, logins, reports and printing or remote storage. If the user prefers, the ezfill+ has a “simple mode” that does not require a login or predefined methods.

“With the growing emphasis on data integrity” says Jeff Seely, Vice President of Sales & Business Development at Distek, Inc., “it is becoming increasingly important to be able to control and document every aspect of your dissolution testing. This is especially true of deaeration and dispensing, which are very common sources of out of spec tests. By having user logins and stored methods included in a printable and/or storable report, these can now be documented with all other parameters of the test.”

To learn more about the new ezfill+ dissolution media preparation system, contact Distek Customer Service at +1 732 422 7585, email at info@distekinc.com or visit www.distekinc.com.

ABOUT DISTEK, INC.

Distek engineers highly innovative, technically modern, and user-friendly instruments that provide many innovative features to customers, worldwide. These include water bath and bathless dissolution, media preparation and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity and dissolution autosampling. Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications as well as the BIOne 1250, an innovative bioreactor control system for both mammalian and microbial models.

Distek’s core market includes brand name, generic and biosimilar drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies and universities. Distek holds several instrumentation and accessory patents and has been ISO certified since 2002.